News & Articles
Pharmaceutical News and Articles
Comprehensive and up-to-date drug news for both consumers and healthcare professionals.
Including medical news, pharmaceutical industry news, new drug approvals, applications and clinical trial results.
Daily MedNews
-- Here are the latest clinical trials, courtesy of CenterWatch and ClinicalConnection.com:
Nocturia
If you wake twice or more during the night to go to the bathroom, you may qualify for this study.
The research site is in Dallas, Texas.
More...
Here are some of the latest health and medical news developments, compiled by editors of HealthDay:
WHO Approves 2nd Cervical Cancer Vaccine
A second cervical cancer vaccine has been approved by the World Health Organization, a decision that opens...
THURSDAY, July 9 -- Respiratory problems experienced by low birth weight infants can persist into adulthood, U.S. researchers report.
Young adults with a history of low birth weight (less than 5.5 pounds at birth) have an increased risk of...
THURSDAY, July 9 -- Severe chronic obstructive pulmonary disease appears linked to lower cognitive function in older adults, making it more difficult for them to remember and perform daily tasks, a new study finds.
Researchers at Mount Sinai School...
THURSDAY, July 9 -- Strokes in American youngsters under the age of 20 cost at least $42 million a year, a new study finds.
The incidence is not high -- between two and four per 100,000 young people annually, said Dr. Warren Lo, lead author of the...
Pharma Industry News
Decision could potentially lead to millions in savings for
Canadians
MISSISSAUGA, ON, July 9 /CNW/ - ratiopharm Canada is pleased to
announce that it has won a five-year legal battle against Pfizer to
allow the marketing of Amlodipine Besylate...
NEW YORK--(BUSINESS WIRE)--Jul 9, 2009 - Pfizer Inc said today
that it is disappointed by the Canadian Federal Court's decision
declaring invalid its patent covering amlodipine besylate, the
active ingredient in Norvasc®, and that the company...
-- GSK’s vaccine to help combat cervical cancer in
developing nations
LONDON,9 July 2009 --The World Health Organization (WHO) has
awarded prequalification to Cervarix®, GlaxoSmithKline’s
cervical cancer vaccine. The WHO decision is...
55% Also Searched User Generated Content Websites For
Health-Related Info
Consumers May Be Looking for Ways to Reduce Spending in Ailing
Economy: Many Switched to a Generic Prescription or OTC Medicine
(32%), Canceled or Delayed a Doctor’s...
New Verilogue Point-of-Practice Report Finds One in Four
Doctor's Visits Include Fear Discussions;
Uncovers Variations in Physician Response
HORSHAM, Pa.--(BUSINESS WIRE)--Jul 8, 2009 - Issues such as
swine flu, peanut butter and cookie batter...
New Drug Approvals
ALIMTA First Chemotherapy Approved As Maintenance Therapy For
Nonsquamous Non-Small Cell Lung Cancer
INDIANAPOLIS, July 6 /PRNewswire-FirstCall/ -- Eli Lilly and
Company (NYSE:LLY)
announced today it received a fourth approval from the U.S....
PARIS, July 02, 2009 /PRNewswire-FirstCall/ --Sanofi-aventis announced today that the U.S. Food and Drug Administration (FDA) has approved Multaq (dronedarone) 400 mg Tablets. Patients with atrial fibrillation (AF) or atrial flutter (AFL) soon will...
LEXINGTON, Mass.--(BUSINESS WIRE)-- AMAG Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Feraheme (ferumoxytol) Injection for intravenous (IV) use as an iron replacement...
ROCKVILLE, Md., June 24, 2009--The U.S. Food and Drug Administration today approved the first generic version of the emergency contraceptive Plan B (levonorgestrel) tablets, 0.75 mg. The generic product will be available by prescription only for...
MONTGOMERY, Ala.--(BUSINESS WIRE)--Jun 22, 2009 - Kowa Pharmaceuticals America, Inc. (KPA), a privately-held specialty pharmaceutical company headquartered in Montgomery, AL, announced today that the U.S. Food and Drug Administration (FDA) has...
New Drug Applications
-- FDA approval requested for oral contraception and
treatment of heavy and/or prolonged menstrual bleeding
Berlin, July 8, 2009 - Bayer has submitted a New Drug
Application (NDA) to the U.S. Food and Drug Administration (FDA)
for a new...
LEXINGTON, Massachusetts, July 6/PRNewswire-FirstCall/ -- Shire
plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, announces that, at the request of the
FDA, in view of a potential restriction on the availability of...
SAN DIEGO--(BUSINESS WIRE)--Jul 7, 2009 - Somaxon
Pharmaceuticals, Inc. (Nasdaq: SOMX), a specialty pharmaceutical
company focused on the in-licensing, development and
commercialization of proprietary branded pharmaceutical products
and...
PALATINE, Ill. and BRISTOL, Tenn., July 2 /PRNewswire-FirstCall/ -- Acura Pharmaceuticals, Inc. and King Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter regarding the New...
Conference Call Thursday, July 2, 2009 at 8:30 AM EDT
WARRINGTON, Pa., July 1, 2009 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) announces today, after receipt of written minutes from the United States Food and Drug...
Clinical Trials
SEATTLE, July 9 /PRNewswire/ -- Dharma
Therapeutics, Inc., ("Dharma") Seattle, WA (a subsidiary of the
Transcu Group Limited, a company listed on the Singapore Exchange
Limited) announced that its improved active transdermal delivery
technology,...
Findings Further Support Leptin as Part of Company's
Integrated Neurohormonal Therapy for Obesity (INTO)
Strategy
SAN DIEGO, July 9 /PRNewswire-FirstCall/ -- Amylin
Pharmaceuticals, Inc. (NASDAQ:AMLN)
today announced positive results from a 28-week...
- Biologics License Application pending for first-in-class
treatment for inhalation anthrax - - HGS has delivered 20,000 doses
of raxibacumab to the U.S. Strategic National Stockpile for
emergency use under a contract with BARDA -
ROCKVILLE, Md.,...
Expected and Manageable Safety Profile Demonstrated in
TASKi2
SOUTH SAN FRANCISCO, Calif., July 9 /PRNewswire-FirstCall/ --
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)
today announced that R788 (fostamatinib disodium) produced
significant clinical...
BOULDER, Colo.--(BUSINESS WIRE)--Jul 8, 2009 - Array BioPharma
Inc. (NASDAQ: ARRY) today announced top-line results from its Phase
1 seven-day dose escalation trial up to 1,200 mg daily of p38
inhibitor, ARRY-797, in healthy volunteers. In addition,...
More News Resources
Daily MedNews
Pharma Industry News
New Drug Applications
New Drug Approvals
Clinical Trial Results
Generic Drug Approvals
Monthly Update Archive
